gepirone has been researched along with Anochlesia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mattiace, LA; McMillen, BA | 1 |
| Futuro-Neto, HA; Pires, JG; Silva, SR | 1 |
2 other study(ies) available for gepirone and Anochlesia
| Article | Year |
|---|---|
Comparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Apomorphine; Buspirone; Catalepsy; Corpus Striatum; Dopamine; Female; Humans; Pyrimidines; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Synaptosomes; Tyrosine 3-Monooxygenase | 1983 |
5-HT2 receptor blockade by ICI 170,809 does not affect the inhibitory effect of the 5-HT1A receptor ligand gepirone on neuroleptic-induced catalepsy.
Topics: Animals; Catalepsy; Male; Pyrimidines; Quinolines; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1994 |